{"type":"rich","author_name":"uneyama","width":"100%","provider_name":"Hatena Blog","url":"https://uneyama.hatenadiary.jp/entry/20101014/p1","blog_url":"https://uneyama.hatenadiary.jp/","title":"\u66f4\u65b0\uff1a\u30ab\u30ca\u30c0\u3067\u306f\u5168\u3066\u306e\u5e02\u8ca9\u30b7\u30d6\u30c8\u30e9\u30df\u30f3\u533b\u85ac\u54c1\u306f\u4efb\u610f\u3067\u56de\u53ce\u3055\u308c\u308b","height":"190","categories":["\u30d8\u30eb\u30b9\u30ab\u30ca\u30c0"],"description":"Update: All Marketed Sibutramine Drugs Voluntarily Withdrawn in Canada October 13, 2010 http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/_2010/2010_172-eng.php 2010\u5e7410\u67088\u65e5\u306eAbbott Laboratories\u306eMeridia\u30ea\u30b3\u30fc\u30eb\u306b\u5f15\u304d\u7d9a\u304d\u3001\u30d8\u30eb\u30b9\u30ab\u30ca\u30c0\u306f\u30b8\u30a7\u30cd\u30ea\u30c3\u30af\u88fd\u54c1Apo-sibutramine\u3068 Novo-sibutramine\u306b\u3064\u3044\u3066\u3082\u60c5\u5831\u3092\u66f4\u65b0\u3059\u308b\u3002","provider_url":"https://hatena.blog","version":"1.0","published":"2010-10-14 00:00:00","author_url":"https://blog.hatena.ne.jp/uneyama/","image_url":null,"blog_title":"\u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Funeyama.hatenadiary.jp%2Fentry%2F20101014%2Fp1\" title=\"\u66f4\u65b0\uff1a\u30ab\u30ca\u30c0\u3067\u306f\u5168\u3066\u306e\u5e02\u8ca9\u30b7\u30d6\u30c8\u30e9\u30df\u30f3\u533b\u85ac\u54c1\u306f\u4efb\u610f\u3067\u56de\u53ce\u3055\u308c\u308b - \u98df\u54c1\u5b89\u5168\u60c5\u5831blog\u904e\u53bb\u8a18\u4e8b\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>"}